In HIV-infected pregnant and breast

In HIV-infected pregnant and breastfeeding women (including pregnant women
in the first trimester of pregnancy and women of childbearing age), a oncedaily
fixed-dose combination of tenofovir + lamivudine (or emtricitabine) +
efavirenz is recommended as first-line ART. This recommendation applies
both to lifelong treatment and to ART initiated for PMTCT and then stopped.
(Strong recommendation, low to moderate quality of evidence)
2 Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations
for a public health approach. Geneva: World Health Organization; 2013. These guidelines will be updated in 2015.

Hasil (Bahasa Indonesia) 1:

Terinfeksi HIV ibu hamil dan menyusui perempuan (termasuk wanita hamilpada trimester pertama kehamilan dan wanita usia subur), oncedailydosis tetap kombinasi tenofovir + lamivudine (atau emtricitabine) +efavirenz dianjurkan sebagai lini pertama seni. Rekomendasi ini berlakukedua perawatan seumur hidup dan seni dimulai untuk PMTCT dan kemudian berhenti.(Rekomendasi kuat, rendah kualitas moderat bukti)2 terkonsolidasi pedoman penggunaan obat antiretroviral untuk mengobati dan mencegah infeksi HIV: rekomendasiuntuk pendekatan kesehatan masyarakat. Jenewa: Organisasi Kesehatan Dunia; 2013. pedoman ini akan diperbarui pada tahun 2015.